Terms: = Colorectal cancer AND FAT4, ENSG00000196159, 79633
20 results:
1. Prognostic Impact of FSTL3, ADAM12, and fat4 in Patients of Colon cancer: Clinicopathologic Study.
Ibrahim HM; Abdelrahman AE; Elwan A; Bakry A; Fahmy MM; Abdelhamid MI; Abdelwanis AH; Fouad EM
Appl Immunohistochem Mol Morphol; 2023 Nov-Dec 01; 31(10):673-681. PubMed ID: 37751246
[TBL] [Abstract] [Full Text] [Related]
2. Exome Sequencing of Paired colorectal Carcinomas and Synchronous Liver Metastases for Prognosis and Therapy Prediction.
Hlaváč V; Červenková L; Šůsová S; Holý P; Liška V; Vyčítal O; Šorejs O; Fiala O; Daum O; Souček P
JCO Precis Oncol; 2023 May; 7():e2200557. PubMed ID: 37141551
[TBL] [Abstract] [Full Text] [Related]
3. Differences in DNA damage repair gene mutations between left- and right-sided colorectal cancer.
Huang W; Li W; Xu N; Li H; Zhang Z; Zhang X; He T; Yao J; Xu M; He Q; Guo L; Zhang S
Cancer Med; 2023 May; 12(9):10187-10198. PubMed ID: 37096801
[TBL] [Abstract] [Full Text] [Related]
4. Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract.
Wu H; Yu Z; Liu Y; Guo L; Teng L; Guo L; Liang L; Wang J; Gao J; Li R; Yang L; Nie X; Su D; Liang Z
Cancer Commun (Lond); 2022 Dec; 42(12):1367-1386. PubMed ID: 36264285
[TBL] [Abstract] [Full Text] [Related]
5. Genomic and transcriptomic analysis of Korean colorectal cancer patients.
Jeon SA; Ha YJ; Kim JH; Kim JH; Kim SK; Kim YS; Kim SY; Kim JC
Genes Genomics; 2022 Aug; 44(8):967-979. PubMed ID: 35751785
[TBL] [Abstract] [Full Text] [Related]
6. Establishing and Validating an Aging-Related Prognostic Four-Gene Signature in Colon Adenocarcinoma.
Zheng L; Yang Y; Cui X
Biomed Res Int; 2021; 2021():4682589. PubMed ID: 34790819
[TBL] [Abstract] [Full Text] [Related]
7. Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.
Zhuang Y; Wang H; Jiang D; Li Y; Feng L; Tian C; Pu M; Wang X; Zhang J; Hu Y; Liu P
BMC Cancer; 2021 Apr; 21(1):380. PubMed ID: 33836681
[TBL] [Abstract] [Full Text] [Related]
8. Mucin 4 mutation is associated with tumor mutation burden and promotes antitumor immunity in colon cancer patients.
Peng L; Li Y; Gu H; Xiang L; Xiong Y; Wang R; Zhou H; Wang J
Aging (Albany NY); 2021 Mar; 13(6):9043-9055. PubMed ID: 33714943
[TBL] [Abstract] [Full Text] [Related]
9. Characterization of genomic alterations in Chinese colorectal cancer patients.
Huang W; Li H; Shi X; Lin M; Liao C; Zhang S; Shi W; Zhang L; Zhang X; Gan J
Jpn J Clin Oncol; 2021 Jan; 51(1):120-129. PubMed ID: 33106877
[TBL] [Abstract] [Full Text] [Related]
10. MiR-106b-5p regulates the migration and invasion of colorectal cancer cells by targeting fat4.
Pan M; Chen Q; Lu Y; Wei F; Chen C; Tang G; Huang H
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33063118
[TBL] [Abstract] [Full Text] [Related]
11. Analysis of genomic pathogenesis according to the revised Bethesda guidelines and additional criteria.
Kim JC; Kim JH; Ha YJ; Kim CW; Tak KH; Yoon YS; Kwon YH; Roh SA; Cho DH; Kim SK; Kim SY; Kim YS
J Cancer Res Clin Oncol; 2021 Jan; 147(1):117-128. PubMed ID: 32960359
[TBL] [Abstract] [Full Text] [Related]
12. Deletions in metastatic colorectal cancer with chromothripsis.
Skuja E; Butane D; Nakazawa-Miklasevica M; Daneberga Z; Purkalne G; Miklasevics E
Exp Oncol; 2019 Dec; 41(4):323-327. PubMed ID: 31868331
[TBL] [Abstract] [Full Text] [Related]
13. Histologic features and genomic alterations of primary colorectal adenocarcinoma predict growth patterns of liver metastasis.
Wu JB; Sarmiento AL; Fiset PO; Lazaris A; Metrakos P; Petrillo S; Gao ZH
World J Gastroenterol; 2019 Jul; 25(26):3408-3425. PubMed ID: 31341365
[TBL] [Abstract] [Full Text] [Related]
14. fat4 regulates the EMT and autophagy in colorectal cancer cells in part via the PI3K-AKT signaling axis.
Wei R; Xiao Y; Song Y; Yuan H; Luo J; Xu W
J Exp Clin Cancer Res; 2019 Mar; 38(1):112. PubMed ID: 30832706
[TBL] [Abstract] [Full Text] [Related]
15. A Specific Mutational Signature Associated with DNA 8-Oxoguanine Persistence in MUTYH-defective colorectal cancer.
Viel A; Bruselles A; Meccia E; Fornasarig M; Quaia M; Canzonieri V; Policicchio E; Urso ED; Agostini M; Genuardi M; Lucci-Cordisco E; Venesio T; Martayan A; Diodoro MG; Sanchez-Mete L; Stigliano V; Mazzei F; Grasso F; Giuliani A; Baiocchi M; Maestro R; Giannini G; Tartaglia M; Alexandrov LB; Bignami M
EBioMedicine; 2017 Jun; 20():39-49. PubMed ID: 28551381
[TBL] [Abstract] [Full Text] [Related]
16. fat4 functions as a tumour suppressor in gastric cancer by modulating Wnt/β-catenin signalling.
Cai J; Feng D; Hu L; Chen H; Yang G; Cai Q; Gao C; Wei D
Br J Cancer; 2015 Dec; 113(12):1720-9. PubMed ID: 26633557
[TBL] [Abstract] [Full Text] [Related]
17. Germline polymorphisms in genes involved in the Hippo pathway as recurrence biomarkers in stages II/III colon cancer.
Sebio A; Matsusaka S; Zhang W; Yang D; Ning Y; Stremitzer S; Stintzing S; Sunakawa Y; Yamauchi S; Fujimoto Y; Ueno M; Lenz HJ
Pharmacogenomics J; 2016 Aug; 16(4):312-9. PubMed ID: 26370619
[TBL] [Abstract] [Full Text] [Related]
18. Target-enriched next-generation sequencing reveals differences between primary and secondary ovarian tumors in formalin-fixed, paraffin-embedded tissue.
Crobach S; Ruano D; van Eijk R; Fleuren GJ; Minderhout I; Snowdowne R; Tops C; van Wezel T; Morreau H
J Mol Diagn; 2015 Mar; 17(2):193-200. PubMed ID: 25545608
[TBL] [Abstract] [Full Text] [Related]
19. Novel recurrently mutated genes and a prognostic mutation signature in colorectal cancer.
Yu J; Wu WK; Li X; He J; Li XX; Ng SS; Yu C; Gao Z; Yang J; Li M; Wang Q; Liang Q; Pan Y; Tong JH; To KF; Wong N; Zhang N; Chen J; Lu Y; Lai PB; Chan FK; Li Y; Kung HF; Yang H; Wang J; Sung JJ
Gut; 2015 Apr; 64(4):636-45. PubMed ID: 24951259
[TBL] [Abstract] [Full Text] [Related]
20. Comparative integromics on FAT1, FAT2, FAT3 and fat4.
Katoh Y; Katoh M
Int J Mol Med; 2006 Sep; 18(3):523-8. PubMed ID: 16865240
[TBL] [Abstract] [Full Text] [Related]
